Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFATC1 | O95644 | 1/20 | 0.35 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | TDO2 | P48775 | 4/20 | 0.33 |
| ▸ | IDO1 | P14902 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | WNT3A | P56704 | 1/20 | 0.33 |
| ▸ | UHRF1 | Q96T88 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | IL5 | P05113 | 1/20 | 0.31 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22373879 | 0.88 | TDO2 (0.41) | NFATC1DYRK1ATDO2IDO1ROCK2 | |
| SCHEMBL22373920 | 0.88 | GABRP (0.37) | NFATC1DYRK1AACHETDO2IDO1 | |
| SCHEMBL11884986 | 0.80 | ACHE (0.37) | DYRK1AACHETDO2IDO1MAPT | |
| SCHEMBL17033990 | 0.80 | AHR (0.47) | CYP1A2CYP2A6MAPTKDM4ENPC1 | |
| SCHEMBL20308132 | 0.79 | ACHE (0.45) | ACHETDO2IDO1CYP1A2MAPT | |
| SCHEMBL23033169 | 0.76 | MAOB (0.41) | CYP1A2CYP2A6UHRF1MAPTKDM4E | |
| SCHEMBL15368227 | 0.76 | ACHE (0.50) | ACHETDO2IDO1CYP1A2MAPT | |
| SCHEMBL22373937 | 0.75 | TDO2 (0.42) | NFATC1DYRK1ATDO2IDO1ROCK2 | |
| SCHEMBL26423389 | 0.75 | NPC1 (0.31) | MAPTKDM4ENPC1ALDH1A1HPGD | |
| SCHEMBL22373875 | 0.74 | L3MBTL1 (0.41) | CYP1A2CYP2A6KDM4ENPC1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230389413-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2023-11-30 | — | — | US | disclosed |
| US-20230389413-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2023-11-30 | — | — | US | disclosed |
| US-11758807-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION | 2023-09-12 | — | — | US | disclosed |
| US-11758807-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION | 2023-09-12 | — | — | US | disclosed |
| US-20200274081-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2020-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230389413-A1 | Organic Electroluminescent Materials and Devices | GLRA3, ESRRG, GLRA1 | NFATC1 3630/4885DYRK1A 2032/4885ACHE 1962/4885 |
| US-20200274081-A1 | Organic Electroluminescent Materials and Devices | GLRA3, ESRRG, GLRA1 | NFATC1 3630/4885DYRK1A 2032/4885ACHE 1962/4885 |
| US-11758807-B2 | Organic electroluminescent materials and devices | GLRA3, ESRRG, GLRA1 | NFATC1 3630/4885DYRK1A 2032/4885ACHE 1962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.